Abstract: A personal selection of 32 recent papers is presented covering various aspects of current developments in bioorganic chemistry and novel natural products such as hitorin A from Chloranthus japonicus.
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Lentinulactam 14, a metabolite of Lentinus cf. fasciatus, has a new skeleton that is proposed to be formed by rearrangement of a hirsutane sesquiterpenoid. 10 The structure of the rearranged norditerpenoid scrodentoid F 15, from Scrophularia dentata, was established by X-ray crystallography. 11 The authors propose that scrodentoid F 15 is formed from a pimarane precursor. The structures of dodovisnoid A 16 from Dodonaea viscosa 12 and hypophyllin A 17 from Hypoestes phyllostachya 13 were also established by X-ray analyses. The authors propose biosynthetic pathways to dodovisnoid A 16 and hypophyllin A 17 from clerodane and labdane diterpenoid precursors, respectively. 
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A combination of genome mining and expression studies has led to the discovery of the biosynthetic gene cluster responsible for the production of the antiplasmodial natural product siphonazole 21 in Herpetosiphon sp. B060. 17 The pathway involves a shikimate starter unit extended by polyketide synthases and nonribosomal peptide synthetases, as well as an unusual termination mechanism that forms the diene terminus of siphonazole. The olefin shift process that occurs during the biosynthesis of the 3-methyl-1,4-pentadiene fragment of ambruticins (e.g. ambruticin VS3 22) has been delineated. 18 The process initially involves a multifunctional domain AmbDH4 that catalyses a dehydration, epimerisation and enoyl isomerisation sequence. The unfavourable equilibrium of this process is then trapped by a C-methyltransferase catalysed α-methylation leading to the pentadiene fragment of the ambruticins.
Using 13 C-labelling and NMR analysis, the mechanism of B-ring contraction during gibberellin biosynthesis in bacteria has been elucidated. 19 which transfers dimethylallyl groups to tryptophan residues during the biosynthesis of kawaguchipeptin A 26, a cyanobactin, has been characterised. 22 The stereoconfiguration of the modified tryptophan residues by KgpF was determined using in An investigation of the enzyme GLligase involved in lipoinitiation of pneumocandins (e.g. 27) in Glarea lozoyensis has resulted in new side-chain analogues. 23 Mutasynthesis experiments showed that GLligase can shuttle various acyl side chains to the nonribosomal peptide synthetase yielding new pneumocandins, some of which showed antifungal activity. The biosynthetic pathway of herquline A 28, a highly strained fungal piperazine alkaloid has been characterised. 24 The Turner group has reported two new biocatalytic approaches for the synthesis of α-amino acids. A one-pot Knoevenagel-Doebner condensation of heteroaromatic derived aldehydes with malonic acid, followed by a phenylalanine ammonia lyase biocatalysed hydroamination has allowed the asymmetric synthesis of Lheteroarylalanines (Scheme 2). 25 In the second approach, a recombinant whole cell system containing an engineered dehydrogenase has been used for the preparation of D-amino acids. 26 Extensive directed evolution of the highly stereoselective mesodiaminopimelate dehydrogenase from Corynebacterium glutamicum produced a biocatalyst that was able to perform reductive amination on a range of aryl derived α-keto acids, forming the corresponding D-amino acids in excellent enantiomeric excess and high yields (Scheme 3).
A recent issue of Tetrahedron (2016, 72, issue 46) has been dedicated to "modern developments in biotransformations" and contain a range of articles on biocatalyst development, including the one-pot preparation of L-dihalotryptophans and Lalkynyltryptophans (Scheme 4) from L-serine and indoles using tryptophan synthase. 27 Extensive protein engineering of the transaminase from Ruegeria sp.
TM1040 has produced a biocatalyst with 8900-fold higher activity than the starting enzyme. 28 The biocatalyst was able to accept particularly bulky substrates, producing pharmaceutically relevant amines with excellent conversions and enantiomeric excess (Scheme 5).
A fungal carboxylate-reducing enzyme (CAR) from Neurospora crassa OR74A has been expressed in E. coli and shown to have broad substrate specificity for a range of aromatic, aliphatic and alkenyl derived carboxylic acids. 29 Application of this wholecell system was demonstrated with the highly efficient gram-scale synthesis of piperonal from piperonylic acid (Scheme 6). Mutation of a single amino acid residue of p-hydroxyphenylacetate 3-hydroxylase (HPAH) from Acinetobacter baumannii has produced a biocatalyst with a wider substrate scope than the wild-type enzyme. 30 Substitution of serine-146, a residue close to the phenolic group binding site for an alanine has allowed the efficient hydroxylation of an aniline substrate with similar activity as the natural phenolic substrate (Scheme 7).
An iron-catalysed dehydrogenation-hydrogenation reaction has been combined with a lipase mediated esterification for the dynamic kinetic resolution of various benzylic, aliphatic and heteroaromatic secondary alcohols (Scheme 8). 31 The dual catalytic process was also used to invert the configuration of an optically pure secondary alcohol and generated the enantiomeric acetate in excellent yield. The enzymatic decarboxylation of cinnamic acids by phenolic acid decarboxylase from Bacillus subtilis (bsPAD) has been combined with a ruthenium catalysed cross metathesis reaction for the one-pot synthesis of stilbenes. 32 The incompatibility of the enzyme reaction that is normally performed under aqueous conditions with the metathesis reaction that requires anhydrous conditions was solved by encapsulation of the decarboxylase in a cryogel. This allowed both steps to be done in methyl tert-butyl ether (MTBE) producing the antioxidant 4,4'-dihydroxystilbene in 90% yield (Scheme 9). 
